Phentermine plus topiramate in the treatment of obesity - ScienceDirect

The Lancet

Volume 378, Issue 9786, 9–15 July 2011, Pages 125-126

The Lancet

https://doi.org/10.1016/S0140-6736(11)61080-5 Get rights and content

References (5)

KM Gadde et al.
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Lancet
(2011)
A Mullard
Mediator scandal rocks French medical community
Lancet
(2011)

There are more references available in the full text version of this article.

Cited by (8)

Progress in researches for antiobesity drugs
2016, Chinese Journal of New Drugs
New pharmacological treatments for the management of obesity
2014, Current Gastroenterology Reports
A review of the metabolic effects of controlled-release Phentermine/Topiramate
2013, Hormones
Phentermine and topiramate for the management of obesity: A review
2013, Drug Design, Development and Therapy
Multifaceted individualities in pharmacological treatments of obesity
2013, Current Clinical Pharmacology
The role of phentermine/topiramate extended-release in the treatment of obesity and obesity-related adverse health consequences
2013, US Endocrinology

View all citing articles on Scopus

Copyright © 2011 Elsevier Ltd. All rights reserved.